INSM

Insmed Incorporated

Healthcare›Biotechnology|NASDAQ Global Select|US

Price

$162.43

Market Cap

$35.01B

Beta

1.17

P/E

0.0

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)+66.73%

EPS Growth (YoY)-14.67%

Revenue CAGR 3Y+35.20%

P/E Ratio0.0

PEG Ratio—

FCF Yield-2.85%

Debt / Equity1.04

Interest Coverage-14.0x

No credit card required

Already have an account? Sign in to view the full analysis for INSM.